Yahoo Finance: Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S. Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System Healio: BERLIN-VT: Timing of ventricular tachycardia ablation does not affect mortality in patients with MI, ICD BERLIN-VT: Timing of ventricular tachycardia ablation does not affect mortality in patients with MI, ICD MassDevice: Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter Adagio Medical wins FDA IDE to expand ventricular ablation study to use next-gen catheter Medscape: High rate of VT recurrence in ARVD/C patients undergoing catheter ablation Healio: Catheter ablation superior to antiarrhythmic drugs in VT with ischemic cardiomyopathy Please provide your email address to receive an email when new articles are posted on .
Catheter ablation improved outcomes vs. antiarrhythmic drugs in patients with VT and ischemic cardiomyopathy. (San Francisco, California) — Ablation of ventricular tachycardia (VT) in patients with verylow ejection fractions (EFs) results in high rates of early recurrence compared with individuals ... NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...
vt ablation, BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ... EurekAlert!: New ablation treatment for ventricular tachycardia reaches deeper into heart muscle Loyola Medicine is among two centers in the world offering a novel catheter ablation system intended to improve treatment outcomes for a life-threatening heart rhythm disorder called ventricular ... Yahoo Finance: Vektor Medical Announces EP Europace Publication: vMap-Guided Ablation Associated with Improved One-Year Arrhythmia-Free Survival in Unstable Ventricular Tachycardia Patients Vektor Medical Announces EP Europace Publication: vMap-Guided Ablation Associated with Improved One-Year Arrhythmia-Free Survival in Unstable Ventricular Tachycardia Patients TCTMD: VT, No Matter Its Source, Benefits From Early Catheter Ablation: PAUSE-SCD Patients with structural heart disease and monomorphic ventricular tachycardia (VT), irrespective of its etiology, can benefit when early first-line catheter ablation is added before implanting an ...
